Hrt Financial LP Red Hill Biopharma Ltd. Transaction History

Hrt Financial LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.31 - $5.85 $29,242 - $74,055	-12,659 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.55 - $10.36 $57,598 - $131,147	12,659 New	12,659 $57,000
Q2 2021 Aug 16, 2021	SELL	$5.98 - $7.51 $96,893 - $121,684	-16,203 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$6.98 - $11.29 $113,096 - $182,931	16,203 New	16,203 $118,000
Q4 2020 Feb 16, 2021	SELL	$7.81 - $10.39 $113,127 - $150,499	-14,485 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$6.34 - $10.83 $91,834 - $156,872	14,485 New	14,485 $148,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.